For the Inventor, By the Inventor

Enter assignee name

Sydney, Australia

Vaxxas Pty Limited

USPTO Granted Patents = 16

EPO Patents = 9

Trademarks = 1

Forward Citations = 79

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Mark Anthony Fernance Kendall (10 out of 17 patents)

Christopher Flaim (6 out of 6 patents)

Michael Carl Junger (5 out of 10 patents)

4. Michael Lawrence Crichton (5 out of 5 patents)

5. Stefano Meliga (3 out of 3 patents)

6. Xi Wang (2 out of 2 patents)

7. Neil Harris (2 out of 2 patents)

8. Sasikaran Kandasamy (2 out of 2 patents)

9. Alexandra Christina Isabelle Depelsenaire (2 out of 2 patents)

10. Pierre Armand Vincent Lemaire (2 out of 2 patents)

11. Germain Fernando (1 out of 2 patents)

12. Xianfeng Chen (1 out of 7 patents)

13. Alexander Bernard Ansaldo (1 out of 1 patent)

14. Robert John Falconer (1 out of 1 patent)

15. Tarl W Prow (1 out of 4 patents)

16 patents: Sort by Forward Citations

1. 12491351 - Delivery device (2025-12-09),

2. 12179485 - Device and method for coating surfaces (2024-12-31),

3. 12090295 - Microprojection arrays with enhanced skin penetrating properties and methods thereof (2024-09-17),

4. 11828584 - Quality control of substrate coatings (2023-11-28),

5. 11653939 - Microprojection arrays with microprojections having large surface area profiles (2023-05-23),

6. 11464957 - Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP) (2022-10-11),

7. 11254126 - Device and method for coating surfaces (2022-02-22),

8. 11207086 - Method of delivering material or stimulus to a biological subject (2021-12-28),

9. 11179553 - Delivery device (2021-11-23),

10. 11175128 - Quality control of substrate coatings (2021-11-16),

11. 11147954 - Microprojection array applicator and method (2021-10-19),

12. 11103259 - Microprojection arrays with microprojections having large surface area profiles (2021-08-31),

13. 10751072 - Delivery device (2020-08-25),

14. 10022322 - Coating method (2018-07-17),

15. 9943673 - Patch applying apparatus (2018-04-17),

Vaxxas Pty Limited is an innovative biotechnology company based in Sydney, Australia, specializing in the development of advanced vaccine delivery technologies. The company focuses on its proprietary nanopatch platform, which aims to enhance the efficacy and accessibility of vaccines through a needle-free delivery method. By leveraging micro-needle technology, Vaxxas seeks to improve immunization rates and patient experiences, contributing to global health initiatives and addressing unmet medical needs in vaccine distribution.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

16 Patents

#12 in Sydney

#230 in Australia

#37,766 in the World

Sydney, Australia

Vaxxas Pty Limited

Forward Citations = 79

16 inventors:

Mark Anthony Fernance Kendall (10 out of 17 patents)

Christopher Flaim (6 out of 6 patents)

Michael Carl Junger (5 out of 10 patents)

4. Michael Lawrence Crichton (5 out of 5 patents)

5. Stefano Meliga (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…